This changed in 2005, with the demonstration that a gene (complement factor H or CFH, a regulator of inflammation) is implicated in up to 50% of cases of AMD in some populations.1 This suggests that AMD may be associated with inflammatory processes rather than primarily being an environmentally determined degenerative disease. Here, CFH is linked to neurodegenerative disease.